Recommended Topic Related To:
Amyvid
FDA Offers New Guidance on Developing Drugs for Alzheimer's Disease »
"Today, the U.S. Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer's disease, before the onset of noticeable (overt) dementia.
Alzheimer’"...
Read the FDA Offers New Guidance on Developing Drugs for Alzheimer's Disease article »
Amyvid
PATIENT INFORMATION
- Instruct patients to inform their physician or healthcare provider if they are pregnant or breastfeeding.
- Inform patients who are breastfeeding to use alternate infant nutrition sources (e.g., stored breast milk or infant formula) for 24 hours (>10 half-lives of radioactive decay for the F 18 isotope) after administration of the drug or avoid use of the drug.
Last reviewed on RxList: 4/16/2012
This monograph has been modified to include the generic and brand name in many instances.
Next: Drug Description
Additional Amyvid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
